Hospira is a drug manufacturer with big problems. It claims it provides “high-quality, lower-cost generic medications”, among other products. In the past year, however, the company has received four warning letters from the FDA. And, within the past several weeks, Hospira “voluntarily” recalled two more drugs, both of which contain strands of glass. According to the company, “glass strands were identified as being affixed to the inside of the vial walls, which had the potential to dislodge into the solution, potentially endangering the patient by inducing vomiting or even embolisms.”
Hospira has a troubling history of problems both in its India plant and the manufacturing facility located in Rocky Mount, NC. In May 2013 The FDA issued a warning letter to the Hospira facility in India referring to unaddressed issues discovered during an inspection in October 2012; included were 6 separate issues relating to sterility practices. The letter noted similar issues were found in a February-March 2013 inspection of the Hospira facility in Rocky Mount, NC.
Looking a little deeper I found a series of recalls on multiple Hospira products, all containing particles or other contaminants. In early March 2013, Hospira recalled lots of five different injectable products. Later that same month, Hospira issued a nationwide recall due to the presence of particles determined to be brass and lead in sodium chloride injections.
continue to read here
No comments:
Post a Comment